It's that time of year where people start thinking about vacations and the possibility of buying that second home somewhere tropical. Bill Furlong, Vice President of Americas at HomeAway, joins Your Future Home to give a few tips on how to settle on the perfect second home. Furlong says that people look for different amenities in a second home and some of them are little more fun than what they would prefer in the main house. Perhaps they want a pool or a hot tub. Some even splurge for an in-home theater or putting green. He says the average person spends around $330,000 on a second home and may rent it out during certain weeks of the year. Plus, before purchasing a second home you need to consider the costs. Furlong says you'll need to budget for new furniture, upkeep, repairs, taxes and seasonal implications such as weatherproofing and lawn care.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More